[HTML][HTML] New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities

M Ashrafizadeh, S Mirzaei, F Hashemi, A Zarrabi… - Biomedicine & …, 2021 - Elsevier
Epithelial-to-mesenchymal transition (EMT) mechanism is responsible for metastasis and
migration of cancer cells to neighboring cells and tissues. Morphologically, epithelial cells …

[HTML][HTML] Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue

V Gote, AR Nookala, PK Bolla, D Pal - International journal of molecular …, 2021 - mdpi.com
Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in
women. This is mainly due to relapse and reoccurrence of tumor. The primary reason for …

[HTML][HTML] Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA

J Szczepanek, M Skorupa, J Jarkiewicz-Tretyn… - International Journal of …, 2023 - mdpi.com
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …

Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer

S Sargazi, B Siddiqui, M Qindeel, A Rahdar, M Bilal… - Carbohydrate …, 2022 - Elsevier
In recent years, gene therapy based on miRNA has been employed as a potential growing
technique for treating various co-morbidities. Direct administration of miRNA is unrealistic …

[HTML][HTML] Chitosan-based nanoparticles for nucleic acid delivery: technological aspects, applications, and future perspectives

M Karayianni, T Sentoukas, A Skandalis, N Pippa… - Pharmaceutics, 2023 - mdpi.com
Chitosan is a naturally occurring polymer derived from the deacetylation of chitin, which is
an abundant carbohydrate found mainly in the shells of various marine and terrestrial …

Human umbilical cord blood-mesenchymal stem cell derived exosomes as an efficient nanocarrier for Docetaxel and miR-125a: Formulation optimization and anti …

M Basak, B Sahoo, DK Chaudhary, SB Narisepalli… - Life Sciences, 2023 - Elsevier
Aim Exosomes, as a nanocarrier for the co-delivery of biologicals and small anticancer
molecules is yet in its infancy. Herein, we investigated hUCBMSC derived exosomes as a …

[HTML][HTML] Therapeutic targeting of MicroRNAs in the tumor microenvironment

R Raue, AC Frank, SN Syed, B Brüne - International journal of molecular …, 2021 - mdpi.com
The tumor-microenvironment (TME) is an amalgamation of various factors derived from
malignant cells and infiltrating host cells, including cells of the immune system. One of the …

[HTML][HTML] Chitosan based microRNA nanocarriers

HH Genedy, T Delair, A Montembault - Pharmaceuticals, 2022 - mdpi.com
Vectorization of microRNAs has shown to be a smart approach for their potential delivery to
treat many diseases (ie, cancer, osteopathy, vascular, and infectious diseases). However …

[HTML][HTML] Treatment of human glioblastoma U251 cells with sulforaphane and a peptide nucleic acid (PNA) targeting miR-15b-5p: synergistic effects on induction of …

J Gasparello, C Papi, M Zurlo, L Gambari, A Rozzi… - Molecules, 2022 - mdpi.com
Glioblastoma multiforme (GBM) is a lethal malignant tumor accounting for 42% of the tumors
of the central nervous system, the median survival being 15 months. At present, no curative …

[HTML][HTML] Chitosomes loaded with docetaxel as a promising drug delivery system to laryngeal cancer cells: an in vitro cytotoxic study

CR Moya-Garcia, NYK Li-Jessen… - International Journal of …, 2023 - mdpi.com
Current delivery of chemotherapy, either intra-venous or intra-arterial, remains suboptimal
for patients with head and neck tumors. The free form of chemotherapy drugs, such as …